Document Mentions (3 shared documents)

EFTA00137138

2 mentions1 same-page

Page ?Same page

receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fight the virus."

ector for Strategic Initiatives Cheryl Davis, AT&T Vice President of Security and Technology Policy Chris Boyer, Parallel Wireless CEO and President Steve Papa, and Hudson Institute's Bryan Clark, Dr Dan Patt, and Tom Duesterberg; 12:00 PM * BPC online discussion on `telehealth' with Independent Sen. Angus

EFTA00148398

2 mentions1 same-page

Page ?Same page

t receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said EFTA00148420 researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fi

ctor for Strategic Initiatives Cheryl Davis, AT&T Vice President of Security and Technology Policy Chris Boyer, Parallel Wireless CEO and President Steve Papa, and Hudson Institute's Bryan Clark, Dr Dan Patt, and Tom Duesterberg; 12:00 PM • BPC online discussion on 'telehealth' with Independent Sen. Angus

EFTA01658735

2 mentions1 same-page

Page ?Same page

t receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fight the virus."